genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Coronavirus
One COVID-19 Shot, Two Approaches
Bioprocessing
Waters Opens Cambridge, MA, Collaboration Lab
Gene Therapy
Laying the Foundation for CF Therapy: An Interview with Michael Boyle
Coronavirus
Beyond the Spike: The COVAXX Approach to a COVID-19 Vaccine
Bioprocessing
Cytiva Plans $500M Expansion, 1,000 New Hires Worldwide
News
Coronavirus
FDA Places Partial Clinical Hold on INOVIO Trial of COVID-19 Vaccine
Coronavirus
BARDA Balks at “Warp Speed” Funding for Oragenics COVID-19 Vaccine
Cancer
Researchers Keep Cancer Cells Out by Blocking the Gate to the…
Alzheimers
Alzheimer’s Epigenetic Drivers Identified
Coronavirus
Specific T Cells Activated in Severe COVID-19 Cases
Insights
All
Trends for 2020
Bioprocessing
Continuous Bioprocessing and 4.0 Tech Key to Bypassing Bottlenecks
Bioprocessing
Cytiva Tests Filtration for Lentivirus Production
Bioprocessing
Observing the Performance of Planova Filters
Bioprocessing
Novel Tech Approaches for Analyzing Aggregation
A-Lists
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Bioprocessing
Continuous Bioprocessing and 4.0 Tech Key to Bypassing Bottlenecks
Bioprocessing
Cytiva Tests Filtration for Lentivirus Production
Coronavirus
FDA Places Partial Clinical Hold on INOVIO Trial of COVID-19 Vaccine
Coronavirus
BARDA Balks at “Warp Speed” Funding for Oragenics COVID-19 Vaccine
Magazine
All
Supplement
September 2020 Vol. 40 No. 9
Cold Cases Heat Up with New Forensic DNA Methods
September 2020 Vol. 40 No. 9
CRISPR Value Chains Support New Therapeutic Strategies
September 2020 Vol. 40 No. 9
Nonviral CRISPR Delivery Vehicles Lay the Smart Siege
Point of View
Multimodal Screening—The Future of Drug Discovery and Development
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Tech Exclusives
Tech Exclusives
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Tech Exclusives
Novel Therapeutic Target Revealed in Lung Squamous Cell Cancer
Tech Exclusives
New Path for Preventing Chronic Myelogenous Leukemia Relapse Discovered
Tech Exclusives
New Method, IDMSeq, Quantifies CRISPR-Cas9 Edits
Tech Exclusives
Potential Biomarker Discovered for Diagnosing Early-Stage Cancer
Tech Exclusives
Researchers Discover a New Side of Cancer that May Explain Its Resistance to Treatment
Tech Exclusives
Carpenter Builds a Broad Cell Imaging Consortium to Accelerate Drug Discovery...
Tech Exclusives
Fatty Acid Induces Cell Death in Cancer Cells
Tech Exclusives
Nonviral Genetic Engineering of CAR T Cells
Tech Exclusives
Speedy Cuts: CRISPR On-Demand Method Developed
Tech Exclusives
Engineered Bacteria Demonstrate Antitumor Activity in Mice
Tech Exclusives
Axon Regeneration Seen for Optic Nerve and Spinal Cord Injuries
Tech Exclusives
COVID-19 Drug Candidates Found by Targeting the Viral Protease
Tech Exclusives
Ovarian Cancer Cells’ Dependence on Fat Opens up Potential New Treatment
Tech Exclusives
Forces Unite to Move Molecular Dx Out of the Gates
Tech Exclusives
Tea for Type 2: Green Tea Triggers Gene Editing System for...
Load more
Scroll Up
Please share your location to continue
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Firm had previously rejected Astellas’ unsolicited bid of roughly $3.5 billion. [© Yuri Arcurs - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/May17_2010_495175_HandshakeBirdsEyeView_AstellasBuysOSI7721122207-2-324x160.jpg "Forces Unite to Move Molecular Dx Out of the Gates")
